Lecanemab-irmb, for intravenous injection, 1 mg
Code effective Apr 01, 2026
HCPCS Section
Drugs administered other than oral method, chemotherapy drugs
J0174 is a valid 2026 HCPCS code meaning Lecanemab-irmb, for intravenous injection, 1 mg or (Lecanemab-irmb, for iv inj) for short. HCPCS J0174 has been effective since 04/01/2026 and applies to Medical care.
|
HCPCS Level II Code Section J - Drugs administered other than oral method, chemotherapy drugs |
|
| HCPCS Code | J0174 |
|---|---|
| Description |
Long description:
Short description: |
| HCPCS Pricing indicator |
00 - Physician Fee Schedule And Non-Physician Practitioners - Service not separately priced by part B (e.g., services not covered, bundled, used by Part A only, etc.)
|
| Multiple pricing indicator |
9 - Not applicable as HCPCS not priced separately by part B or value is not established
|
| Coverage code | C - Carrier judgment |
| ASC payment group code | Effective Jul 06, 2023 - This procedure is approved to be performed in an ambulatory surgical center. |
| BETOS2 code | O1E - Other drugs |
| HCPCS Action code | C - Change in long description of procedure or modifier code |
| Type of service | 1 - Medical care |
| Effective date | Effective Apr 01, 2026 |
| Date added | Added Jul 06, 2023 |
1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).
2 BETOS stands for “Berenson-Eggers Type Of Service”
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026
CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.